1 Lu, S.-M. & Alper, H. (2005) Intramolecular carbonylation reactions with recyclable palladium-complexed dendrimers on silica: synthesis of oxygen, nitrogen, or sulfur-containing medium ring fused heterocycles. J. Am. Chem. Soc., 127, 14776–14784.
2 Nasr, T., Bondock, S. & Eid, S. (2014) Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety. Eur. J. Med. Chem., 84, 491–504.
3 Gutsche, C. D. & Lin, L.-G. (1986) Calixarenes 12: the synthesis of functionalized calixarenes. Tetrahedron, 42, 1633–1640.
4 Lavanya, R. Sulphonamides: (2017) A Pharmaceutical Review. Int. J. Pharm. Sci. Invent., 6, 03.
5 Wang, X. L., Wan, K. & Zhou, C. H. (2010) Synthesis of novel sulfanilamide-derived 1,2,3-triazoles and their evaluation for antibacterial and antifungal activities. Eur. J. Med. Chem., 45, 4631–4639.
6 Nasr, T., Bondock, S. & Eid, S. (2016) Design, synthesis, antimicrobial evaluation and molecular docking studies of some new 2,3-dihydro thiazoles and 4-thiazolidinones containing sulfisoxazole. J. Enzyme Inhib. Med. Chem., 31, 236–246.
7 Supuran, C. T. (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Discov., 7, 168.
8 Garaj, V., Puccetti, L., Fasolis, G., Winum, J. Y., Montero, J. L., Scozzafava, A., ... & Supuran, C. T. (2004) Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumour-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1, 2, 4-triazine moieties. Bioorg. Med. Chem. Lett. 14, 5427–5433.
9 Ghorab, M. M., Alsaid, M. S., Al-Dosari, M. S., Nissan, Y. M. & Al-Mishari, A. A. (2016) Novel chloroquinoline derivatives incorporating biologically active benzenesulfonamide moiety: Synthesis, cytotoxic activity and molecular docking. Chem. Cent. J. 10, 1–13.
10 Thaisrivongs, S., Skulnick, H. I., Turner, S. R., Strohbach, J. W., Tommasi, R. A., Johnson, P. D., ... & Romines, K. R. (1996) Structure-based design of HIV protease inhibitors: Sulfonamide- containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. J. Med. Chem. 39, 4349–4353.
11 Zhao, Z., Wolkenberg, S. E., Lu, M., Munshi, V., Moyer, G., Feng, M., ... & Prasad, S. G. (2008) Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). Bioorganic Med. Chem. Lett. 18, 554–559.
12 Unsal-Tan, O., Ozadali, K., Piskin, K. & Balkan, A. (2012) Molecular modelling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity. Eur. J. Med. Chem. 57, 59–64.
13 Schultz, L. J., Steketee, R. W., Macheso, A., Kazembe, P., Chitsulo, L., & Wirima, J. J. (1994) The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am. J. Trop. Med. Hyg. 51, 515–522.
14 Bunyapraphatsara, N., Yongchaiyudha, S., Rungpitarangsi, V. & Chokechaijaroenporn, O. (1996) Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 3, 245–248.
15 Boolell, M., Allen, M. J., Ballard, S. A., Gepi-Attee, S., Muirhead, G. J., Naylor, A. M., ... & Gingell, C. (1996) Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. 8, 47–52.
16 Penning, T. D., Talley, J. J., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., ... & Rogers, R. S. (1997) Synthesis and biological evaluation of the 1, 5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1 H-pyrazol-1-yl] benzenesulfonamide (SC-58635, celecoxib). J. Med. Chem. 40, 1347–1365.
17 Lee, S. & Park, S. B. (2009) An Efficient One-Step Synthesis of Heterobiaryl Pyrazolo [3, 4- b ] pyridines via Indole Ring Opening.
18 Rizk, H. F. (2012) Synthesis of pyrazolo [3, 4- b ] pyridines under microwave irradiation in multicomponent reactions and their antitumor and antimicrobial activities e Part 1. Eur. J. Med. Chem. 48, 92–96.
19 Bernardino, A. M. R., de Azevedo, A. R., da Silva Pinheiro, L. C., Borges, J. C., Carvalho, V. L., Miranda, M. D., ... & Da Silva, V. A. G. G. (2007) Synthesis and antiviral activity of new 4-(phenylamino)/4-[(methylpyridin-2-yl) amino]-1-phenyl-1H-pyrazolo [3, 4-b] pyridine-4-carboxylic acids derivatives. Med. Chem. Res. 16, 352–369.
20 Dias, L. R. S., Alvim, M. J., Freitas, A. C. C., Barreiro, E. J. & Miranda, A. L. P. (1994) Synthesis and analgesic properties of 5-acyl-arylhydrazone 1-H pyrazolo [3, 4-b] pyridine derivatives. Pharm. Acta Helv. 69, 163–169.
21 Sharma, P. K., Singh, K., Kumar, S., Kumar, P., Dhawan, S. N., Lal, S., ... & Dannhardt, G. (2011) Synthesis and anti-inflammatory evaluation of some pyrazolo[3,4-b]pyridines. Med. Chem. Res. 20, 239–244.
22 Ma, Y., Sun, G., Chen, D., Peng, X., Chen, Y. L., Su, Y., ... & Ding, J. (2015) Design and Optimization of a Series of 1- Sulfonylpyrazolo[4,3-b ]pyridines as Selective c-Met Inhibitors. doi:10.1021/jm502018y
23 Li, Y., Cheng, H., Zhang, Z., Zhuang, X., Luo, J., Long, H., ... & Patterson, A. (2015) N-(3-Ethynyl-2,4-di fluorophenyl)sulfonamide Derivatives as Selective Raf Inhibitors. 3–7. doi:10.1021/acsmedchemlett.5b00039
24 Abdel-Monem, Y. K., Abou El-Enein, S. A. & El-Sheikh-Amer, M. M. (2017) Design of new metal complexes of 2-(3-amino-4,6-dimethyl-1H-pyrazolo[3,4-b]pyridin-1-yl)aceto-hydrazide: Synthesis, characterization, modelling and antioxidant activity. J. Mol. Struct. 1127, 386–396.
25 Chandak, N., Kumar, S. & Kumar, P. (2013) Exploration of antimicrobial potential of pyrazolo [3,4-b] pyridine scaffold bearing benzenesulfonamide and trifluoromethyl moieties. doi:10.1007/s00044-013-0544-1
26 Bhoi, M. N., Borad, M. A., Pithawala, E. A. & Patel, H. D. (2016) Novel benzothiazole containing 4 H -pyrimido [2,1- b] benzothiazoles derivatives : One pot, solvent-free microwave assisted synthesis and their biological evaluation. Arab. J. Chem. doi:10.1016/j.arabjc.2016.01.012
27 Nishikimi, M., Rao, N. A. & Yagi, K. (1972) The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 46, 849–854.
28 Liu, N., Wang, Y., Huang, G., Ji, C., Fan, W., Li, H., ... & Tian, H. (2016) Design, synthesis and biological evaluation of 1H-pyrrolo [2, 3- b ] pyridine and 1H-pyrazolo [3,4-b] pyridine derivatives as c-Met inhibitors. Bioorg. Chem. 65, 146–158.